This paper reviews theoretical and empirical literature that originated predominantly during and after TRIPS, focusing on the influence of changes in patent protection on developing countries. Previous studies identify two channels of gain for developing countries, from strong patent rights. Firstly, the promotion channel whereby, patent rights affect innovativeness of the South and concomitantly its economic growth. Theoretical studies do not give unambiguous hypotheses concerning the influence of patent protection on domestic innovation leaving it for empirical investigation.

In recent years, patenting has been considered one of the major drivers for enhancing national competitiveness and most of the advanced countries have been more actively enforcing patent protection. However, the indicators proposed in previous studies have not been able to deal adequately with the various dimensions of patenting, rather focusing on patent application counts. Therefore, in this research, a comprehensive patent performance indicator is proposed to provide a yardstick by which government policymakers can evaluate the whole process of converting patents into economic assets.

Your data on changing stock prices for five pharmaceutical companies from 1997 to 2010 (Nature 480, 16–17; 2011) erroneously indicate a 39% drop in aggregated share value, when in fact it would have risen by 82% (see Correction, Nature 480, 425; 2011). The error was due mainly to the selection of unadjusted, rather than adjusted, stock-market closing prices. (Correspondence)

The present study tries to explore the factors that influence the growth, performance, and development of IPR attitude of small and medium-sized enterprises (SMEs) in the manufacturing sector of Punjab. The aim of the present research is to examine the technology management strategies of manufacturing SMEs, primarily on the basis of use-based classification.

Reed Beall and Randall Kuhn describe their findings from an analysis of use of compulsory licenses for pharmaceutical products by World Trade Organization members since 1995.

Original Source

The very nature of traditional Chinese medicine (TCM) poses serious challenges in patenting intellectual property. Unlike modern medicines, which are based on newly discovered, developed or isolated chemical compounds, TCM prescriptions typically consist of mixtures of well-known plant or animal extracts. Moreover, these recipes are public knowledge, having been recorded in ancient books, and are therefore ineligible for patents in areas where a compound's novelty is a prerequisite.